Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Enhancing Lesbian, Gay, Bisexual, and Transgender Cultural Competence in a Midwestern Primary Care Clinic Setting.

Felsenstein DR.

J Nurses Prof Dev. 2018 May/Jun;34(3):142-150. doi: 10.1097/NND.0000000000000450.

2.

Distinct plasma immune signatures in ME/CFS are present early in the course of illness.

Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, Peterson DL, Gottschalk CG, Schultz AF, Che X, Eddy ML, Komaroff AL, Lipkin WI.

Sci Adv. 2015 Feb;1(1). pii: e1400121.

3.

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, Hayden D, Shui A, Brooks B, Conwit R, Felsenstein D, Greenblatt DJ, Keroack M, Kissel JT, Miller R, Rosenfeld J, Rothstein JD, Simpson E, Tolkoff-Rubin N, Zinman L, Shefner JM; Ceftriaxone Study Investigators.

Lancet Neurol. 2014 Nov;13(11):1083-1091. doi: 10.1016/S1474-4422(14)70222-4. Epub 2014 Oct 5.

4.

Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.

Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME; Northeast ALS Consortium.

PLoS One. 2013 Apr 17;8(4):e61177. doi: 10.1371/journal.pone.0061177. Print 2013.

5.

Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.

Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, Marty FM, Lin NH, Grazioso P, Crochiere DM, Eggers D, Kuritzkes DR, Tsibris AM.

J Infect Dis. 2010 Nov 15;202(10):1478-81. doi: 10.1086/657168. Epub 2010 Oct 11.

6.

Ocular syphilis among HIV-infected patients: a systematic analysis of the literature.

Tucker JD, Li JZ, Robbins GK, Davis BT, Lobo AM, Kunkel J, Papaliodis GN, Durand ML, Felsenstein D.

Sex Transm Infect. 2011 Feb;87(1):4-8. doi: 10.1136/sti.2010.043042. Epub 2010 Aug 26. Review.

7.

Ocular syphilis among HIV-infected individuals.

Li JZ, Tucker JD, Lobo AM, Marra CM, Davis BT, Papaliodis GN, Felsenstein D, Durand ML, Yawetz S, Robbins GK.

Clin Infect Dis. 2010 Aug 15;51(4):468-71. doi: 10.1086/654797.

8.

Case records of the Massachusetts General Hospital. Case 39-2005. A 63-year-old woman with a positive serologic test for syphilis and persistent eosinophilia.

Ryan ET, Felsenstein D, Aquino SL, Branda JA, Morgan JG.

N Engl J Med. 2005 Dec 22;353(25):2697-705. No abstract available.

9.

"Shotgun" versus sequential testing. Cost-effectiveness of diagnostic strategies for vaginitis.

Carr PL, Rothberg MB, Friedman RH, Felsenstein D, Pliskin JS.

J Gen Intern Med. 2005 Sep;20(9):793-9.

10.

Evaluation and management of vaginitis.

Carr PL, Felsenstein D, Friedman RH.

J Gen Intern Med. 1998 May;13(5):335-46. Review.

11.

Survey of health care providers: who sees patients needing STD services, and what services do they provide?

Moran JS, Kaufman JA, Felsenstein D.

Sex Transm Dis. 1995 Jan-Feb;22(1):67-9. No abstract available.

PMID:
7709328
12.

Bacon therapy and furuncular myiasis.

Brewer TF, Wilson ME, Gonzalez E, Felsenstein D.

JAMA. 1993 Nov 3;270(17):2087-8.

PMID:
8411575
13.

Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus.

Johns DR, Tierney M, Felsenstein D.

N Engl J Med. 1987 Jun 18;316(25):1569-72.

PMID:
3587290
14.

Ophthalmoscopic and histologic findings in cytomegalovirus retinitis treated with BW-B759U.

D'Amico DJ, Talamo JH, Felsenstein D, Hirsch MS, Albert DM, Schooley RT.

Arch Ophthalmol. 1986 Dec;104(12):1788-93.

PMID:
3024605
15.

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS.

N Engl J Med. 1985 Dec 12;313(24):1493-7.

PMID:
2999591
16.

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

Plotkin SA, Drew WL, Felsenstein D, Hirsch MS.

J Infect Dis. 1985 Oct;152(4):833-4. No abstract available.

PMID:
2995505
17.

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.

Felsenstein D, D'Amico DJ, Hirsch MS, Neumeyer DA, Cederberg DM, de Miranda P, Schooley RT.

Ann Intern Med. 1985 Sep;103(3):377-80.

PMID:
2992334
18.

Phenotypic properties of atypical lymphocytes in cytomegalovirus-induced mononucleosis.

Felsenstein D, Carney WP, Iacoviello VR, Hirsch MS.

J Infect Dis. 1985 Jul;152(1):198-203.

PMID:
2989382
19.

Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).

Hirsch MS, Wormser GP, Schooley RT, Ho DD, Felsenstein D, Hopkins CC, Joline C, Duncanson F, Sarngadharan MG, Saxinger C, et al.

N Engl J Med. 1985 Jan 3;312(1):1-4.

PMID:
2981106
20.

Antineutrophil antibodies in infectious mononucleosis.

Schooley RT, Densen P, Harmon D, Felsenstein D, Hirsch MS, Henle W, Weitzman S.

Am J Med. 1984 Jan;76(1):85-90.

PMID:
6318560
21.

Cytomegalovirus-induced immunosuppression.

Hirsch MS, Felsenstein D.

Ann N Y Acad Sci. 1984;437:8-15. Review. No abstract available.

PMID:
6100012

Supplemental Content

Loading ...
Support Center